Literature DB >> 18239402

Fibrostenotic Crohn's disease.

Florian Froehlich1, Pascal Juillerat, Christian Mottet, Valérie Pittet, Christian Felley, John-Paul Vader, Jean-Jacques Gonvers, Pierre Michetti.   

Abstract

Crohn's disease is often complicated by gastrointestinal strictures. Postoperative recurrence at the anastomotic site is common and repeated surgical interventions may be necessary. Medical treatment may relieve active inflammation (see chapter on active luminal disease) but fibrous strictures will not respond to this. Mechanical treatment methods consist of endoscopic balloon dilation, stricturoplasty or surgical resection. Fibrostenotic Crohn's disease does not respond to medical therapy and requires endoscopic or surgical treatment. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18239402     DOI: 10.1159/000111025

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  10 in total

Review 1.  A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety.

Authors:  Ronald Ambe; Lorna Campbell; Burt Cagir
Journal:  J Gastrointest Surg       Date:  2011-09-10       Impact factor: 3.452

2.  Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.

Authors:  Angela C Baird; Frances Lloyd; Ian C Lawrance
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

3.  Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.

Authors:  Sarah N Flier; Harikrishna Tanjore; Efi G Kokkotou; Hikaru Sugimoto; Michael Zeisberg; Raghu Kalluri
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts.

Authors:  Ping Li; Mei-Lan Liang; Ying Zhu; Yao-Yao Gong; Yun Wang; Ding Heng; Lin Lin
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Long term follow up of through-the-scope balloon dilation as compared to strictureplasty and bowel resection of intestinal strictures in crohn's disease.

Authors:  Ekaterina Krauss; Abbas Agaimy; Angelina Gottfried; Juergen Maiss; Thomas Weidinger; Heinz Albrecht; Arndt Hartmann; Werner Hohenberger; Markus F Neurath; Hermann Kessler; Jonas Mudter
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Triptolide ameliorates colonic fibrosis in an experimental rat model.

Authors:  Qingsong Tao; Baochai Wang; Yu Zheng; Guanwei Li; Jianan Ren
Journal:  Mol Med Rep       Date:  2015-04-01       Impact factor: 2.952

7.  The correlation between tenascin-C expression, and formation of intestinal stricture.

Authors:  Emrullah Erdem; Koray Kochan; Nurcan Paker; Yasemin Gokden; Ayca Salturk Degirmenci; Fatin Kocak; Can Gonen
Journal:  North Clin Istanb       Date:  2015-01-24

8.  Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition.

Authors:  Su Xu; Bin Jiang; Hui Wang; Cunsi Shen; Hao Chen; Li Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-22       Impact factor: 2.629

9.  Atractylenolide III inhibits epithelial‑mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway.

Authors:  Mingjin Huang; Wenwen Jiang; Chunli Luo; Min Yang; Yan Ren
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 3.423

10.  Toll-like receptor 4 regulates intestinal fibrosis via cytokine expression and epithelial-mesenchymal transition.

Authors:  Yu Kyung Jun; So Hyun Kwon; Hee Tae Yoon; Hyunsun Park; Hosim Soh; Hyun Jung Lee; Jong Pil Im; Joo Sung Kim; Ji Won Kim; Seong-Joon Koh
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.